Reuters logo
2 months ago
BRIEF-Veloxis Pharmaceuticals Q1 operating loss narrows to $5.2 mln
May 17, 2017 / 5:25 AM / 2 months ago

BRIEF-Veloxis Pharmaceuticals Q1 operating loss narrows to $5.2 mln

1 Min Read

May 17 (Reuters) - VELOXIS PHARMACEUTICALS A/S:

* Said on Tuesday q1 Revenue $4.0 Mln vs $1.5 Mln Yr Ago

* q1 Operating Loss $5.2 Mln vs Loss $6.9 Mln Yr Ago

* q1 Net Loss $5.9 Mln vs Loss $7.1 Mln Yr Ago

* VELOXIS MAINTAINS ITS 2017 OUTLOOK OF OPERATING LOSS BEFORE THE RECOGNITION OF INCOME FROM LICENSE AGREEMENTS AND BEFORE ACCOUNTING FOR STOCK COMPENSATION TO BE IN THE RANGE OF USD 5 – 15 MILLION.

Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below